Produkty 251316-91-3

CAS 251316-91-3 występuje w naszej ofercie pod nazwami: Fmoc–Nle–Nle–OH, Fmoc-Nle-Nle-OH, (2S)-2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanamido]hexanoic acid, ≥95%, ≥95%. Oferty producentów: GLPBio, Biosynth, Chemat. Dostępne opakowania: 1g, 5g, 2000mg, 1000mg, 5000mg.

Fmoc–Nle–Nle–OH
GLPBio
  • opakowanie: 1g, 5g
  • Warianty: 2
od 2558,17
Zobacz produkt
Fmoc-Nle-Nle-OH
Biosynth
  • opakowanie: 2000mg, 1000mg, 5000mg
  • Warianty: 3
Zobacz produkt
(2S)-2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanamido]hexanoic acid, ≥95%, ≥95%
Chemat
  • opakowanie: 1g, 5g
  • Warianty: 2
od 1326,80
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoyl]amino]hexanoic acid (CAS 251316-91-3) to związek chemiczny o wzorze sumarycznym C27H34N2O5 i masie molowej 466.6 g/mol. Nazwa systematyczna IUPAC: (2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoyl]amino]hexanoic acid. InChIKey: ZKMWKHIVYXYTMB-ZEQRLZLVSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H34N2O5
Masa molowa466.6 g/mol
Nazwa IUPAC(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoyl]amino]hexanoic acid
InChIKeyZKMWKHIVYXYTMB-ZEQRLZLVSA-N
SMILESCCCC[C@@H](C(=O)N[C@@H](CCCC)C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Dane obliczone przez PubChem (NCBI)

Synonimy: Fmoc-Nle-Nle-OH, (N-Fmoc-L-norleucyl)-L-norleucine
Izomery (ten sam wzór sumaryczny)
(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoyl]amino]-4-methylpentanoic acid C27H34N2O5
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(octanoylamino)butanoic acid C27H34N2O5
3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-1H-3-benzazepin-2-one C27H34N2O5
ethyl (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylate C27H34N2O5
ethyl (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylate C27H34N2O5
5-methoxy-N-[3-methoxy-4-(2-piperidin-2-ylethoxy)phenyl]-2,2-dimethylchromene-6-carboxamide C27H34N2O5
tert-butyl 6-[[6-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-4-oxopyran-3-yl]oxymethyl]-2-azaspiro[3.3]heptane-2-carboxylate C27H34N2O5
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-(hexanoylamino)hexanoic acid C27H34N2O5
methyl 6-[(1S,2R)-1-hydroxy-2-methoxycarbonyl-9-methyldecyl]phenazine-1-carboxylate C27H34N2O5
24-hydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.07,14.09,13]octacosa-5,11,16,18-tetraene-2,20,27,28-tetrone C27H34N2O5
3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-(trideuteriomethyl)amino]propyl]-7,8-dimethoxy-1H-3-benzazepin-2-one C27H34N2O5
(2S,3S)-2-[[(2S,3S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylpentanoyl]amino]-3-methylpentanoic acid C27H34N2O5